Skip to main content
VCbacked
Log inGet Started

TwinStrand Biosciences

Seattle, United States

TwinStrand Biosciences develops and commercializes the duplex sequencing technology for DNA sequencing.

$10.3M raised
Jun 2023
Venture - Series Unknown
BiotechnologyGeneticsHealth Care

Top Investors

MadronaS32Soleus CapitalJanus Henderson InvestorsAlexandria Venture Investments

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about TwinStrand Biosciences

How much funding has TwinStrand Biosciences raised?
TwinStrand Biosciences has raised $10.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2023.
Who are TwinStrand Biosciences's investors?
TwinStrand Biosciences's investors include Madrona, S32, Soleus Capital, Janus Henderson Investors, Alexandria Venture Investments.
Where is TwinStrand Biosciences headquartered?
TwinStrand Biosciences is headquartered in Seattle, United States.
What does TwinStrand Biosciences do?
TwinStrand Biosciences develops and commercializes the duplex sequencing technology for DNA sequencing.
What stage is TwinStrand Biosciences at?
TwinStrand Biosciences is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"TwinStrand Biosciences — Funding & Investors." VCBacked, June 30, 2023, https://www.vcbacked.co/company/twinstrand-biosciences. Accessed June 27, 2026.
APA
VCBacked. (2023). TwinStrand Biosciences — Funding & Investors. Retrieved June 27, 2026, from https://www.vcbacked.co/company/twinstrand-biosciences
Wikipedia (cite web)
{{cite web |title=TwinStrand Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/twinstrand-biosciences |website=VCBacked |access-date=June 27, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong